Literature DB >> 20929651

Risk factors for disease severity among hospitalised patients with 2009 pandemic influenza A (H1N1) in Spain, April - December 2009.

P Santa-Olalla Peralta1, M Cortes-García, M Vicente-Herrero, C Castrillo-Villamandos, P Arias-Bohigas, I Pachon-del Amo, M J Sierra-Moros.   

Abstract

We describe the clinical and epidemiological characteristics of patients hospitalised with confirmed 2009 pandemic influenza A(H1N1) in Spain from April to December 2009 and the risk factors associated with a worse outcome (admission to an intensive care unit or death) in adults. Case-based epidemiological information was collected as part of the national strategy for the surveillance of severe cases. Of 3,025 patients, 852 were admitted to an intensive care unit and overall, 200 died. The median patient age was 38 years (range: 0–94). A total of 662 (26%) patients had no underlying risk conditions. Antiviral therapy was initiated within 48 hours after symptom onset in only 35.2% (n=711); the median length of time before treatment was four days. In a multivariate analysis, the start of antiviral therapy more than 48 hours after symptom onset (odds ratio (OR) 2.39; 95% confidence interval (CI): 1.79 to 3.2), morbid obesity (OR: 2.01; 95% CI 1.38 to 2.94), cardiovascular disease (OR: 1.79; 95% CI: 1.2 to 2.67) and chronic obstructive pulmonary disease (OR: 1.51; 95% CI: 1.03 to 2.2) were significantly associated with a worse outcome in adults.

Entities:  

Mesh:

Year:  2010        PMID: 20929651     DOI: 10.2807/ese.15.38.19667-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  36 in total

Review 1.  The influence of virus infections on the course of COPD.

Authors:  H Frickmann; S Jungblut; T O Hirche; U Groß; M Kuhns; A E Zautner
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

Review 2.  Inflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE).

Authors:  Daniel J Raiten; Fayrouz A Sakr Ashour; A Catharine Ross; Simin N Meydani; Harry D Dawson; Charles B Stephensen; Bernard J Brabin; Parminder S Suchdev; Ben van Ommen
Journal:  J Nutr       Date:  2015-04-01       Impact factor: 4.798

3.  Obesity Increases Mortality and Modulates the Lung Metabolome during Pandemic H1N1 Influenza Virus Infection in Mice.

Authors:  J Justin Milner; Jenny Rebeles; Suraj Dhungana; Delisha A Stewart; Susan C J Sumner; Matthew H Meyers; Peter Mancuso; Melinda A Beck
Journal:  J Immunol       Date:  2015-04-10       Impact factor: 5.422

Review 4.  Influenza Pathogenesis: The Effect of Host Factors on Severity of Disease.

Authors:  Anshu P Gounder; Adrianus C M Boon
Journal:  J Immunol       Date:  2019-01-15       Impact factor: 5.422

Review 5.  The impact of obesity on the immune response to infection.

Authors:  J Justin Milner; Melinda A Beck
Journal:  Proc Nutr Soc       Date:  2012-03-14       Impact factor: 6.297

Review 6.  The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma.

Authors:  Richard Hewitt; Hugo Farne; Andrew Ritchie; Emma Luke; Sebastian L Johnston; Patrick Mallia
Journal:  Ther Adv Respir Dis       Date:  2015-11-26       Impact factor: 4.031

7.  Absence of β6 Integrin Reduces Influenza Disease Severity in Highly Susceptible Obese Mice.

Authors:  Victoria Meliopoulos; Brandi Livingston; Lee-Ann Van de Velde; Rebekah Honce; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

8.  Influenza A/H1N1 2009 pandemic and respiratory virus infections, Beijing, 2009-2010.

Authors:  Yaowu Yang; Zhong Wang; Lili Ren; Wei Wang; Guy Vernet; Gláucia Paranhos-Baccalà; Qi Jin; Jianwei Wang
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

9.  Utility of the first few100 approach during the 2009 influenza A(H1N1) pandemic in the Netherlands.

Authors:  Arianne B van Gageldonk-Lafeber; Marianne Ab van der Sande; Adam Meijer; Ingrid Hm Friesema; Gé A Donker; Johan Reimerink; Mirna Robert-Du Ry van Beest Holle; Jan M Prins; Leslie Isken; François G Schellevis; Mariken Im van der Lubben
Journal:  Antimicrob Resist Infect Control       Date:  2012-09-21       Impact factor: 4.887

Review 10.  Assessment of the Association of COPD and Asthma with In-Hospital Mortality in Patients with COVID-19. A Systematic Review, Meta-Analysis, and Meta-Regression Analysis.

Authors:  Felix M Reyes; Manuel Hache-Marliere; Dimitris Karamanis; Cesar G Berto; Rodolfo Estrada; Matthew Langston; George Ntaios; Perminder Gulani; Chirag D Shah; Leonidas Palaiodimos
Journal:  J Clin Med       Date:  2021-05-13       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.